Physician profile
Grace E Kong
NPI 1386836336
$1,850.76
in general payments reported to CMS, 2019-2025
24 companies · $82.41 in 2025
The $82.41 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $215 · 2021: $294 · 2022: $523 · 2023: $158 · 2024: $174 · 2025: $82.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $394.02 | 2019-2022 | |
| Pfizer INC. | $198.82 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.92 | 2019-2025 | |
| Organon LLC | $145.47 | 2021-2022 | |
| Therapeuticsmd, INC. | $137.84 | 2019-2021 | |
| Aspira Women'S Health INC | $122.43 | 2021-2024 | Ova1 |
| Coopersurgical, INC. | $86.86 | 2019-2023 | Summit Doppler |
| Lupin INC. | $84.84 | 2019-2020 | |
| Myovant Sciences INC. | $63.96 | 2021-2022 | |
| Exeltis, USA INC. | $63.74 | 2020-2022 | |
| Evofem Biosciences, INC. | $57.90 | 2021-2022 | |
| Channel Medsystems, INC. | $47.49 | 2022-2023 | |
| Minerva Surgical, INC | $45.73 | 2024 | |
| Merck Sharp & Dohme LLC | $40.41 | 2021-2022 | |
| Biogen, INC. | $34.18 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $32.42 | 2022 | |
| Smith+Nephew, INC. | $25.74 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Astellas Pharma US INC | $24.90 | 2023 | Veozah |
| Daiichi Sankyo INC. | $24.09 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $22.18 | 2025 | Myfembree |
| Amgen INC. | $15.02 | 2019 | |
| Agile Therapeutics, INC. | $12.48 | 2021 | |
| Covidien Lp | $11.56 | 2019 | |
| Meditrina | $10.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.